Market Cap | ₹588Cr |
ROE | 14.72% |
P/E Ratio(TTM) | 25.06 |
EPS(TTM) | 49.65 |
P/B Ratio | 4.15 |
Dividend Yield | 0.06% |
Industry P/E | 40.61 |
Book Value | 299.47 |
Debt to Equity | 1.18 |
Face Value | 10 |
Parent Organisation | Fredun Pharmaceuticals Ltd |
Managing Director | Mr. Fredun Medhora |
BSE Symbol | 539730 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 60.29 | ||
Gland Pharma | NA (0.00%) | 43.15 | ||
Ajanta Pharma | NA (0.00%) | 34.21 | ||
Eris Lifesciences | NA (0.00%) | 57.62 |